Investments
TBV invests across the spectrum of private life science companies from early to late stage including private placements (ie PIPES) from public companies.
The TBV approach to private equity investing includes the following characteristics to enhance its ability to deliver superior returns in the fund:
•
Focus. Life Science is our sole focus, providing considerable benefits from an in depth understanding of industry characteristics.
•
Global Network. The network that TBV has built extends across academic, consulting, legal, venture capital and investment banking circles. This provides a significant advantage throughout the spectrum of an investment, from evaluation to exit. The world-class advice and service we can access allows us to add considerable value to the venture capital process and more likely to reap an attractive return for our investors.
•
Disciplined Financial Framework. Key to our investment strategy is a focus on investing only in what is commercially attractive science and technology within our investment timeframe.
•
Risk Management. At all times risk management is paramount. The portfolio will be constructed to ensure no over-exposure occurs to a particular company, sector or stage of development. Extensive due diligence is a hallmark of our approach and will be applied equally to the company and individuals involved in a transaction.
•
Financial Engineering. Ensuring that investments are structured to maximise the probability of success and focused on alignment of interest between stakeholders. Critical to this is ensuring financial investors have appropriate protection mechanisms in place to minimise downside whilst maximising the potential upside.